<DOC>
	<DOCNO>NCT00143624</DOCNO>
	<brief_summary>This trial study effect rosiglitazone progression atherosclerosis ( harden blood vessel ) improvement sugar fat metabolism ( body buildup , breakdown excretion sugar fat ) . Participants randomly assign one two group : first group receive 8 mg study drug second group give placebo , though neither group know formulation receiving . The study follow group one year , measure change blood vessel composition activity , sugar metabolism , concentration blood fat , body fat distribution . This single-site study aim enroll 50 participant .</brief_summary>
	<brief_title>Rosiglitazone ( AvandiaÂ® ) Treatment HIV : Its Effect Blood Vessels</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>HIVpositive Between 30 70 year age Elevated blood level fat On two antiHIV drug least12 month row unlikely change antiHIV therapy study On stable regimen least 6 month woman take oral contraceptive agent hormone replacement On stable regimen least 6 month men testosterone replacement If take nevirapine , therapy least 3 month stable liver function test Pregnancy breastfeed Poorly control diabetes Uncontrolled hypertension clinical evidence heart failure Any serious medical condition , include active AIDSdefining condition , pancreatitis , hepatitis within 6 month prior study Laboratory abnormality ( see investigator ) On lipid lower agent , insulin , anabolic steroid ( except testosterone replacement dos ) , oral corticosteroid great replacement dos , growth hormone History liver reaction severe edema associate current thiazolidinedione History hypersensitivity thiazolidinedione</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Treatment Experienced</keyword>
	<keyword>HIV Metabolic Syndrome</keyword>
	<keyword>Atherosclerosis HIV</keyword>
</DOC>